top of page
Medical Checkup

CALM

Trial Enrolment Status

OPEN

Disease Under Study

Chronic Cough

Duration

~52 Weeks

About the Trial

Utilizing BLU-5937 in Adult Participants with Refractory Chronic Cough, Including Unexplained Chronic Cough

Mechanism of Action:

P2X3 Antagonist

Dr. George Philteos

Principal Investigator

Dr. George Philteos

Sub-Investigator

Dr. Anushya Chelvanathan

Study Coordinator

Kristen Palandra

bottom of page